These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 31003756

  • 1. Familial chylomicronemia syndrome: A rare but devastating autosomal recessive disorder characterized by refractory hypertriglyceridemia and recurrent pancreatitis.
    Chyzhyk V, Brown AS.
    Trends Cardiovasc Med; 2020 Feb; 30(2):80-85. PubMed ID: 31003756
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an "FCS score".
    Moulin P, Dufour R, Averna M, Arca M, Cefalù AB, Noto D, D'Erasmo L, Di Costanzo A, Marçais C, Alvarez-Sala Walther LA, Banach M, Borén J, Cramb R, Gouni-Berthold I, Hughes E, Johnson C, Pintó X, Reiner Ž, van Lennep JR, Soran H, Stefanutti C, Stroes E, Bruckert E.
    Atherosclerosis; 2018 Aug; 275():265-272. PubMed ID: 29980054
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Familial chylomicronemia syndrome: Bringing to life dietary recommendations throughout the life span.
    Williams L, Rhodes KS, Karmally W, Welstead LA, Alexander L, Sutton L, patients and families living with FCS.
    J Clin Lipidol; 2018 Aug; 12(4):908-919. PubMed ID: 29804909
    [Abstract] [Full Text] [Related]

  • 8. Current Diagnosis and Management of Primary Chylomicronemia.
    Okazaki H, Gotoda T, Ogura M, Ishibashi S, Inagaki K, Daida H, Hayashi T, Hori M, Masuda D, Matsuki K, Yokoyama S, Harada-Shiba M.
    J Atheroscler Thromb; 2021 Sep 01; 28(9):883-904. PubMed ID: 33980761
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Diagnostic algorithm for familial chylomicronemia syndrome.
    Stroes E, Moulin P, Parhofer KG, Rebours V, Löhr JM, Averna M.
    Atheroscler Suppl; 2017 Jan 01; 23():1-7. PubMed ID: 27998715
    [Abstract] [Full Text] [Related]

  • 13. The burden of familial chylomicronemia syndrome: Results from the global IN-FOCUS study.
    Davidson M, Stevenson M, Hsieh A, Ahmad Z, Roeters van Lennep J, Crowson C, Witztum JL.
    J Clin Lipidol; 2018 Jan 01; 12(4):898-907.e2. PubMed ID: 29784572
    [Abstract] [Full Text] [Related]

  • 14. Long-term clinical outcomes and management of hypertriglyceridemia in children with Apo-CII deficiency.
    Yoldas Celik M, Canda E, Yazici H, Erdem F, Yuksel Yanbolu A, Atik Altinok Y, Pariltay E, Akin H, Kalkan Ucar S, Coker M.
    Nutr Metab Cardiovasc Dis; 2024 Jul 01; 34(7):1798-1806. PubMed ID: 38503616
    [Abstract] [Full Text] [Related]

  • 15. Disappearance of recurrent pancreatitis after splenectomy in familial chylomicronemia syndrome.
    Marco-Benedí V, Lamiquiz-Moneo I, Álvarez-Sala LA, Civeira F.
    Atherosclerosis; 2018 Aug 01; 275():342-345. PubMed ID: 30015297
    [Abstract] [Full Text] [Related]

  • 16. Clinical and biochemical features of different molecular etiologies of familial chylomicronemia.
    Hegele RA, Berberich AJ, Ban MR, Wang J, Digenio A, Alexander VJ, D'Erasmo L, Arca M, Jones A, Bruckert E, Stroes ES, Bergeron J, Civeira F, Witztum JL, Gaudet D.
    J Clin Lipidol; 2018 Aug 01; 12(4):920-927.e4. PubMed ID: 29748148
    [Abstract] [Full Text] [Related]

  • 17. A Comprehensive Update on the Chylomicronemia Syndrome.
    Goldberg RB, Chait A.
    Front Endocrinol (Lausanne); 2020 Aug 01; 11():593931. PubMed ID: 33193106
    [Abstract] [Full Text] [Related]

  • 18. Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia.
    Caddeo A, Mancina RM, Pirazzi C, Russo C, Sasidharan K, Sandstedt J, Maurotti S, Montalcini T, Pujia A, Leren TP, Romeo S, Pingitore P.
    Nutr Metab Cardiovasc Dis; 2018 Feb 01; 28(2):158-164. PubMed ID: 29288010
    [Abstract] [Full Text] [Related]

  • 19. The burden of familial chylomicronemia syndrome in Canadian patients.
    Gaudet D, Stevenson M, Komari N, Trentin G, Crowson C, Hadker N, Bernard S.
    Lipids Health Dis; 2020 Jun 02; 19(1):120. PubMed ID: 32487261
    [Abstract] [Full Text] [Related]

  • 20. Challenges in familial chylomicronemia syndrome diagnosis and management across Latin American countries: An expert panel discussion.
    Santos RD, Lorenzatti A, Corral P, Nogueira JP, Cafferata AM, Aimone D, Lourenço CM, Izar MC, Lima JG, Lottenberg AM, Alonso R, Garay K, Morales AR, Vargas-Uricoechea H, Peña CAC, Roman-González A.
    J Clin Lipidol; 2021 Jun 02; 15(5):620-624. PubMed ID: 34920815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.